<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03804827</url>
  </required_header>
  <id_info>
    <org_study_id>181121</org_study_id>
    <nct_id>NCT03804827</nct_id>
  </id_info>
  <brief_title>Sleep Disordered Breathing in Acute Congestive Heart Failure</brief_title>
  <official_title>Impact of Sleep Disordered Breathing on Cardiac Injury in Acutely Decompensated Congestive Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine if sleep disordered breathing results in a measurable&#xD;
      degree of overnight myocardial stress/injury in patients with acutely decompensated&#xD;
      congestive heart failure. A secondary goal is to determine of a period of medical management&#xD;
      attenuates this sleep disordered breathing-induced cardiac injury in this patient population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consecutive patients admitted to the hospital with acutely decompensated heart failure will&#xD;
      be identified for potential enrollment in this study. Enrolled patients will first be asked&#xD;
      to complete questionnaires to assess their symptoms and risk of having sleep apnea.&#xD;
&#xD;
      Relevant information will be obtained from the electronic medical record (age, gender, body&#xD;
      mass index, co-morbidities, medications, prior echocardiography results). Subjects will then&#xD;
      undergo a &quot;type III&quot; portable monitoring sleep study on the first or second night of their&#xD;
      hospital admission, which measures respiratory effort, nasal airflow, oxyhemoglobin&#xD;
      saturation, and heart rate. Blood samples will be collected on the evening before (08:00 PM&#xD;
      +/- 2 hours), and the morning after (06:00 AM +/-2 hours) sleep apnea testing. If not&#xD;
      otherwise obtained clinically, echocardiography will be obtained within 48 hours of&#xD;
      admission. After a period of medical management for acutely decompensated heart failure,&#xD;
      subjects will then have a second portable sleep apnea study (with associated pre and&#xD;
      post-sleep blood draws) on the evening prior to discharge (approximately hospital day 5 or&#xD;
      6). Later, clinical outcomes such as incidence of renal dysfunction, hospital length of stay&#xD;
      etc. will be collected from the electronic medical record. Blood samples will be processed,&#xD;
      stored, and subsequently analyzed for high-sensitivity cardiac troponin T and I.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 14, 2019</start_date>
  <completion_date type="Actual">August 3, 2021</completion_date>
  <primary_completion_date type="Actual">August 3, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overnight Troponin Change Admission</measure>
    <time_frame>10 hours</time_frame>
    <description>Overnight change in serum troponin concentration PRE vs POST sleep</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overnight Troponin Change Discharge</measure>
    <time_frame>10 hours</time_frame>
    <description>Overnight change in serum troponin concentration PRE vs POST sleep</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">19</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Heart Failure; With Decompensation</condition>
  <arm_group>
    <arm_group_label>Heart Failure With Sleep Disordered Breathing</arm_group_label>
    <description>AHI3% &gt;/= 5 events per hour of sleep.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart Failure without Sleep Disordered Breathing</arm_group_label>
    <description>AHI3% &lt; 5 events per hour of sleep.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum retention&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients admitted to University of California San Diego Sulpizio Cardiovascular&#xD;
        Center, Jacobs Medical Center, and Thornton Hospital with acutely decompensated heart&#xD;
        failure will be identified in the emergency department, or upon admission to the cardiology&#xD;
        or hospitalist (general medical) service.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients age 18-80 years admitted to University of California San Diego La Jolla&#xD;
             campus (Sulpizio Cardiovascular Center, Jacobs Medical Center, and Thornton Hospital)&#xD;
             with acute decompensated heart failure will be identified in the emergency department,&#xD;
             or upon admission to the cardiology or inpatient general medical services.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known diagnosis of sleep disordered breathing and on treatment while hospitalized.&#xD;
&#xD;
          -  Suspected acute coronary syndrome as determined by the primary clinical team.&#xD;
&#xD;
          -  Intensive care unit level care.&#xD;
&#xD;
          -  Requiring advanced heart failure therapy such as inotrope infusion, mechanical&#xD;
             circulatory support etc.&#xD;
&#xD;
          -  Intolerance of study procedures.&#xD;
&#xD;
          -  Clinical attending physician refusal&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Altman Clinical and Translational Research Institute</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093-0990</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 11, 2019</study_first_submitted>
  <study_first_submitted_qc>January 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2019</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Robert L. Owens</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Sleep</keyword>
  <keyword>OSA</keyword>
  <keyword>CSA</keyword>
  <keyword>CHF</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Troponin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

